Arthritis Research & Therapy

official impact factor 4.36

Bone loss: Therapeutic approaches for preventing bone loss in inflammatory arthritis

Qaiser Rehman and Nancy E Lane*

  • * Corresponding author: Nancy E Lane

Arthritis Res Ther 2001, 3:221-227 doi:10.1186/ar305

Accesses  

  • Last 30 days: 33 accesses
  • Last 365 days: 565 accesses
  • All time: 8367 accesses

Cited by

BioMed Central: 3 citations

Research article   Open Access Highly Accessed

Bone destruction by receptor activator of nuclear factor κB ligand-expressing T cells in chronic gouty arthritis

Sung-Ji Lee, Kwang-Il Nam, Hye-Mi Jin, Young-Nan Cho, Song-Eun Lee, Tae-Jong Kim, Shin-Seok Lee, Seung-Jung Kee, Keun-Bae Lee, Nacksung Kim, Yong-Wook Park Arthritis Research & Therapy 2011, 13:R164 (13 October 2011)

Commentary   Free

Rheumatoid arthritis as a hyper-endoplasmic reticulum-associated degradation disease

Satoshi Yamasaki, Naoko Yagishita, Kaneyuki Tsuchimochi, Kusuki Nishioka, Toshihiro Nakajima Arthritis Research & Therapy 2005, 7:181-186 (17 August 2005)

Research article   Open Access Highly Accessed

Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]

Helena Forsblad d'Elia, Stephan Christgau, Lars-Åke Mattsson, Tore Saxne, Claes Ohlsson, Elisabeth Nordborg, Hans Carlsten Arthritis Res Ther 2004, 6:R457-R468 (6 August 2004)